Vontobel Holding’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Buy |
1,487
+159
| +12% | +$45.7K | ﹤0.01% | 834 |
|
|
2025
Q1 | $409K | Sell |
1,328
-27
| -2% | -$8.32K | ﹤0.01% | 841 |
|
|
2024
Q4 | $478K | Sell |
1,355
-309
| -19% | -$109K | ﹤0.01% | 801 |
|
|
2024
Q3 | $596K | Buy |
1,664
+790
| +90% | +$283K | ﹤0.01% | 738 |
|
|
2024
Q2 | $278K | Sell |
874
-3,784
| -81% | -$1.21M | ﹤0.01% | 909 |
|
|
2024
Q1 | $1.07M | Sell |
4,658
-303
| -6% | -$69.6K | 0.01% | 565 |
|
|
2023
Q4 | $1.09M | Buy |
4,961
+3,834
| +340% | +$843K | 0.01% | 569 |
|
|
2023
Q3 | $255K | Buy |
1,127
+154
| +16% | +$34.8K | ﹤0.01% | 940 |
|
|
2023
Q2 | $215K | Buy |
+973
| New | +$215K | ﹤0.01% | 995 |
|
|
2022
Q3 | – | Sell |
-2,000
| Closed | -$477K | – | 1109 |
|
|
2022
Q2 | $477K | Buy |
+2,000
| New | +$477K | 0.01% | 735 |
|